Form 4 for AXGN Axogen, Inc.
Accepted 2026-05-08 16:06:46 ET · period of report 2026-05-07 · accession 0000805928-26-000067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-08 16:06 | 2026-05-07 | AXGN | Hartley Lindsey Marie | CFO | M - OptEx | $8.24 | +5,463 | 65.7K | +9% | +$45.0K |
| DM | 2026-05-08 16:06 | 2026-05-07 | AXGN | Hartley Lindsey Marie | CFO | S - Sale+OE | $43.67 | -1,051 | 65.1K | -2% | -$45.9K |
| DM | 2026-05-08 16:06 | 2026-05-07 | AXGN | Hartley Lindsey Marie | CFO | M - OptEx | $0.00 | -5,463 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-07 | M | A | 2,500 | $8.20 | 63,234 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-07 | S | D | 478 | $43.67 | 62,756 | D | — | — | |
| 3 | Common | Common Stock | 2026-05-07 | M | A | 2,963 | $8.27 | 65,719 | D | — | — | |
| 4 | Common | Common Stock | 2026-05-07 | S | D | 573 | $43.67 | 65,146 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to purchase) | 2026-05-07 | M | D | 2,500 | $0.00 | 0 | D | $8.20 · — to 2032-03-16 | 2,500 Common Stock | (F1) All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested on March 16, 2026. |
| 6 | Derivative | Employee Stock Option (right to purchase) | 2026-05-07 | M | D | 2,963 | $0.00 | 0 | D | $8.27 · — to 2033-03-16 | 2,963 Common Stock | (F2) All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. |